Grants per year
Fingerprint
Dive into the research topics where David E Nix is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pharmacokinetics &pharmacodynamics of anti-inflammatory botanicals
Nix, D. E. (PI)
Project: Research project
-
ARIZONA CENTER FOR PHYTOMEDICINE RESEARCH (ACPRX)
Mayersohn, M. (CoPI) & Nix, D. E. (CoPI)
Project: Research project
-
EVALUATION OF NIKKOMYCIN Z PHARMACOLOGY FOR TREATMENT OF UNCOMPLICATED COCCIDIODE
Nix, D. E. (PI)
7/1/07 → 6/30/10
Project: Research project
-
Considerations When Using Body Mass Index as a Size Descriptor
Erstad, B. L. & Nix, D. E., Jan 2023, In: Annals of Pharmacotherapy. 57, 1, p. 107-109 3 p.Research output: Contribution to journal › Comment/debate › peer-review
1 Scopus citations -
Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin C
Erstad, B. L. & Nix, D. E., Jun 7 2023, In: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 80, 12, p. 712-718 7 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Performance of Bayesian Area Under the Concentration-Time Curve-Based Pharmacokinetic Dosing Based on a One-Compartment Model and Trough-Only Monitoring for Vancomycin
Salehpour, N., Riley, L. D., Gonzales, M. J., Kobic, E. & Nix, D. E., Jun 2023, In: Antimicrobial Agents and Chemotherapy. 67, 6Research output: Contribution to journal › Article › peer-review
-
Risk for primary cephalosporin resistance in Gram-negative bacteremia
John, P., Shahbazian, S., Lainhart, W. D., Hayes, J., Mochon, B. & Nix, D. E., Jul 10 2023, In: Antimicrobial Stewardship and Healthcare Epidemiology. 3, 1, e121.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
Al-Obaidi, M. M., Ostrosky-Zeichner, L. & Nix, D. E., Aug 1 2023, In: Open Forum Infectious Diseases. 10, 8, ofad345.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Datasets
-
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
Eljaaly, K. (Creator), Alshehri, S. (Creator), Aljabri, A. (Creator), Abraham, I. (Creator), Al Mohajer, M. (Contributor), Kalil, A. C. (Creator) & Nix, D. E. (Creator), figshare, 2017
DOI: 10.6084/m9.figshare.c.3794578.v1, https://figshare.com/collections/Clinical_failure_with_and_without_empiric_atypical_bacteria_coverage_in_hospitalized_adults_with_community-acquired_pneumonia_a_systematic_review_and_meta-analysis/3794578/1
Dataset
-
Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
Eljaaly, K. (Creator), Alshehri, S. (Creator), Aljabri, A. (Creator), Abraham, I. (Creator), Al Mohajer, M. (Contributor), Kalil, A. C. (Creator) & Nix, D. E. (Creator), figshare, 2017
DOI: 10.6084/m9.figshare.c.3794578, https://figshare.com/collections/Clinical_failure_with_and_without_empiric_atypical_bacteria_coverage_in_hospitalized_adults_with_community-acquired_pneumonia_a_systematic_review_and_meta-analysis/3794578
Dataset